Cargando…
Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan
INTRODUCTION: Fluoroquinolones (FQs) is a distinct class of antibiotics which are prescribed and used quite frequently worldwide, despite the box warnings (BW) issued by Food and Drug Administration (FDA). Literature has shown in spite of BWs related to FQs there is minimal impact on health care pro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680351/ https://www.ncbi.nlm.nih.gov/pubmed/38012805 http://dx.doi.org/10.1186/s40545-023-00674-6 |
_version_ | 1785150708061831168 |
---|---|
author | Abbas, Muhammad Kashmiri, Kashif Rehman, Inayat Ur Ali, Zahid Rahman, Aziz Ur Khalil, Asad Ming, Long Chiau Shafique, Muhammad Khan, Tahir Mehmood |
author_facet | Abbas, Muhammad Kashmiri, Kashif Rehman, Inayat Ur Ali, Zahid Rahman, Aziz Ur Khalil, Asad Ming, Long Chiau Shafique, Muhammad Khan, Tahir Mehmood |
author_sort | Abbas, Muhammad |
collection | PubMed |
description | INTRODUCTION: Fluoroquinolones (FQs) is a distinct class of antibiotics which are prescribed and used quite frequently worldwide, despite the box warnings (BW) issued by Food and Drug Administration (FDA). Literature has shown in spite of BWs related to FQs there is minimal impact on health care professionals (HCPs) prescribing habits, potentially attributing towards limited and insufficient awareness. In Pakistan, FQs are mostly prescribed antibiotics for microbial treatments, therefore the purpose of this study was to determine the level of knowledge about the safety profile, use, and BW of FQs among HCPs working in Pakistan. METHODS: A cross-sectional study was undertaken among the HCPs of Khyber Pakhtunkhwa province of Pakistan from October 2022 to December 2022. A validated questionnaire was used to assess the knowledge of HCPs regarding FQs, its safety profile and BW. A random convenient sample technique was used while recruiting HCPs in this study. As the HCPs comprised physicians, dentists, pharmacist and nurses, all were approached in person and the study objective was fully elaborated and explained to them. The statistic test like: one-way ANOVA, independent-t test, multivariate logistic regression were used keeping the p-value < 0.05 as statistically significant. RESULTS: A total of n = 250 HCPs were approached, of which n = 186 HCPs completed the questionnaire with a response rate of 74.4%. FQs prescribing pattern was only assessed among the prescribers, i.e., physicians and dentists (39/186). The mean knowledge score for indications was 5.29 ± 3.05, while for the adverse effects was 7.70 ± 2.61. The highest score for knowledge for indications and adverse effect score was achieved by physicians followed by dentist. The mean knowledge score for the BW was 3.46 ± 2.93 and among the HCPs for the BW of FQs, 20.4% of the HCPs had appropriate knowledge score (score ≥ 50%). The knowledge score was significantly higher in males (p = 0.039), dentists (p = 0.001), HCPs having master/specialization level of education (p = 0.003), HCPs working in government sector hospitals (p = 0.010) and secondary care hospitals (p = 0.001) while the multivariate logistic regression analysis showed that HCPs working in primary care hospital (OR: 6.2) and secondary care hospital (OR: 20.3) were associated with the tendency to achieve 50% or above knowledge score. CONCLUSION: Findings of this study reveals the unsatisfactory knowledge of HCPs regarding the safety profile, use, and BW of FQs putting patients at heightened risks of FQs associated AEs. Therefore, it is crucial to implement a national antimicrobial stewardship program, seminars and lectures aimed at continuously updating the knowledge of HCPs, regardless of their specialties, and effectively restrict the misuse of antimicrobial and disseminate FDA BWs in clinical practice. |
format | Online Article Text |
id | pubmed-10680351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106803512023-11-27 Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan Abbas, Muhammad Kashmiri, Kashif Rehman, Inayat Ur Ali, Zahid Rahman, Aziz Ur Khalil, Asad Ming, Long Chiau Shafique, Muhammad Khan, Tahir Mehmood J Pharm Policy Pract Research INTRODUCTION: Fluoroquinolones (FQs) is a distinct class of antibiotics which are prescribed and used quite frequently worldwide, despite the box warnings (BW) issued by Food and Drug Administration (FDA). Literature has shown in spite of BWs related to FQs there is minimal impact on health care professionals (HCPs) prescribing habits, potentially attributing towards limited and insufficient awareness. In Pakistan, FQs are mostly prescribed antibiotics for microbial treatments, therefore the purpose of this study was to determine the level of knowledge about the safety profile, use, and BW of FQs among HCPs working in Pakistan. METHODS: A cross-sectional study was undertaken among the HCPs of Khyber Pakhtunkhwa province of Pakistan from October 2022 to December 2022. A validated questionnaire was used to assess the knowledge of HCPs regarding FQs, its safety profile and BW. A random convenient sample technique was used while recruiting HCPs in this study. As the HCPs comprised physicians, dentists, pharmacist and nurses, all were approached in person and the study objective was fully elaborated and explained to them. The statistic test like: one-way ANOVA, independent-t test, multivariate logistic regression were used keeping the p-value < 0.05 as statistically significant. RESULTS: A total of n = 250 HCPs were approached, of which n = 186 HCPs completed the questionnaire with a response rate of 74.4%. FQs prescribing pattern was only assessed among the prescribers, i.e., physicians and dentists (39/186). The mean knowledge score for indications was 5.29 ± 3.05, while for the adverse effects was 7.70 ± 2.61. The highest score for knowledge for indications and adverse effect score was achieved by physicians followed by dentist. The mean knowledge score for the BW was 3.46 ± 2.93 and among the HCPs for the BW of FQs, 20.4% of the HCPs had appropriate knowledge score (score ≥ 50%). The knowledge score was significantly higher in males (p = 0.039), dentists (p = 0.001), HCPs having master/specialization level of education (p = 0.003), HCPs working in government sector hospitals (p = 0.010) and secondary care hospitals (p = 0.001) while the multivariate logistic regression analysis showed that HCPs working in primary care hospital (OR: 6.2) and secondary care hospital (OR: 20.3) were associated with the tendency to achieve 50% or above knowledge score. CONCLUSION: Findings of this study reveals the unsatisfactory knowledge of HCPs regarding the safety profile, use, and BW of FQs putting patients at heightened risks of FQs associated AEs. Therefore, it is crucial to implement a national antimicrobial stewardship program, seminars and lectures aimed at continuously updating the knowledge of HCPs, regardless of their specialties, and effectively restrict the misuse of antimicrobial and disseminate FDA BWs in clinical practice. BioMed Central 2023-11-27 /pmc/articles/PMC10680351/ /pubmed/38012805 http://dx.doi.org/10.1186/s40545-023-00674-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Abbas, Muhammad Kashmiri, Kashif Rehman, Inayat Ur Ali, Zahid Rahman, Aziz Ur Khalil, Asad Ming, Long Chiau Shafique, Muhammad Khan, Tahir Mehmood Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan |
title | Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan |
title_full | Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan |
title_fullStr | Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan |
title_full_unstemmed | Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan |
title_short | Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan |
title_sort | evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in pakistan |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680351/ https://www.ncbi.nlm.nih.gov/pubmed/38012805 http://dx.doi.org/10.1186/s40545-023-00674-6 |
work_keys_str_mv | AT abbasmuhammad evaluationofhealthcareprofessionalsunderstandingoffluoroquinolonessafetyprofileusageandboxedwarningsinpakistan AT kashmirikashif evaluationofhealthcareprofessionalsunderstandingoffluoroquinolonessafetyprofileusageandboxedwarningsinpakistan AT rehmaninayatur evaluationofhealthcareprofessionalsunderstandingoffluoroquinolonessafetyprofileusageandboxedwarningsinpakistan AT alizahid evaluationofhealthcareprofessionalsunderstandingoffluoroquinolonessafetyprofileusageandboxedwarningsinpakistan AT rahmanazizur evaluationofhealthcareprofessionalsunderstandingoffluoroquinolonessafetyprofileusageandboxedwarningsinpakistan AT khalilasad evaluationofhealthcareprofessionalsunderstandingoffluoroquinolonessafetyprofileusageandboxedwarningsinpakistan AT minglongchiau evaluationofhealthcareprofessionalsunderstandingoffluoroquinolonessafetyprofileusageandboxedwarningsinpakistan AT shafiquemuhammad evaluationofhealthcareprofessionalsunderstandingoffluoroquinolonessafetyprofileusageandboxedwarningsinpakistan AT khantahirmehmood evaluationofhealthcareprofessionalsunderstandingoffluoroquinolonessafetyprofileusageandboxedwarningsinpakistan |